Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00858949 · ClinicalTrials.gov registry record
Costs of Postoperative Nausea and Vomiting in Ambulatory Surgery Patients
A clinical trial of Postoperative Nausea and Vomiting, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT00858949 is a study of Postoperative Nausea and Vomiting that has completed, run by The Cleveland Clinic. The registered enrollment target is 100 participants, below the 460-participant average among 9 other Postoperative Nausea and Vomiting trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00858949, a study of Postoperative Nausea and Vomiting, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an observational study with the goal of determining the costs of nausea and vomiting in ambulatory patients after surgery from the US societal perspective.
Conditions Studied
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2008-08 |
| Est. Completion | 2009-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00858949
The ClinicalTrials.gov registry entry for NCT00858949 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 460-participant average among 9 other Postoperative Nausea and Vomiting trials with a reported enrollment target (78% lower). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Postoperative Nausea and Vomiting appearing as the primary indexed condition, and to 0 interventions.
NCT00858949 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT00858949 about?
NCT00858949 is a clinical study titled "Costs of Postoperative Nausea and Vomiting in Ambulatory Surgery Patients". This is an observational study with the goal of determining the costs of nausea and vomiting in ambulatory patients after surgery from the US societal perspective.
What is the current status of trial NCT00858949?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2008-08. Estimated completion is 2009-11.
What conditions does trial NCT00858949 study?
This clinical trial studies the following conditions: Postoperative Nausea and Vomiting.
Who is sponsoring clinical trial NCT00858949?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00858949 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postoperative Nausea and Vomiting
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Use of Transcutaneous Electrical Nerve Stimulation Device, Reletex Reliefband, With Current ERAS (Enhanced Recovery After Surgery) Protocol to Further Decrease Postoperative Nausea and Vomiting in the Bariatric Surgical Patient Within the First 24 Hours Postoperatively.
RECRUITING · NA
-
Preoperative Use of Pantoprazole for Prevention of Post Operative Nausea and Vomiting in Gynecologic Surgery
RECRUITING · Phase 2
-
Clinical Use of Baxter Animated Retching Faces (BARF) Scale in Children
COMPLETED
-
Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women
COMPLETED · Phase 3
-
Study of APD421 as PONV Treatment (Prior Prophylaxis)
COMPLETED · Phase 3
-
Combination Antiemetic Regimen for Prevention of PONV in Breast Surgery Patients
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.